Almujtama Alraida Medical Co.
9592.SRSAUHealthcare● Active
$24.60
+$1.10(+4.68%)
Market Cap$233700000
P/E Ratio—
52W High$33.5
52W Low$22
Almujtama Alraida Medical Co. (9592.SR) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · 9592.SR · as of 2026-06-15
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.45B | $0.43B | $0.41B | $0.37B | $0.30B |
| Cost of Revenue | $0.30B | $0.29B | $0.28B | $0.27B | $0.24B |
| Gross Profit | $0.15B | $0.14B | $0.13B | $0.10B | $0.06B |
| Gross Margin %(computed) | 32.93% | 32.99% | 31.69% | 26.34% | 20.23% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $0.00B | $0.00B | $0.00B | $0.01B | $0.00B |
| Total Operating Expenses | $0.14B | $0.13B | $0.12B | $0.07B | $0.05B |
| Operating Income | $0.01B | $0.01B | $0.01B | $0.03B | $0.01B |
| Operating Margin %(computed) | 2.36% | 2.16% | 3.42% | 7.00% | 3.26% |
| Interest Income | $0.00B | $0.00B | $0.00B | ($0.00B) | ($0.00B) |
| Interest Expense | $0.01B | $0.01B | $0.01B | $0.00B | $0.00B |
| Income Before Tax | $0.01B | $0.01B | $0.01B | $0.02B | $0.01B |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | $0.01B | $0.01B | $0.01B | $0.02B | $0.01B |
| Net Margin %(computed) | 1.85% | 1.84% | 2.79% | 5.20% | 2.56% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $0.88 | $0.83 | $1.20 | $2.01 | $0.82 |
| Wtd Avg Shares | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B |
| EBITDA | $0.01B | $0.06B | $0.05B | $0.05B | $0.03B |
| EBITDA Margin %(computed) | 2.36% | 13.62% | 12.40% | 13.01% | 11.34% |
Data source: Financial Modeling Prep · Last updated: 2026-06-15 · SAR · B
Explore more Almujtama Alraida Medical Co. data
About Almujtama Alraida Medical Co. (9592.SR) Income Statement
Almujtama Alraida Medical Co. (9592.SR) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, 9592.SR reported revenue of $0.45B, gross profit of $0.15B (gross margin 32.93%), and net income of $0.01B — a net profit margin of 1.85%.
Frequently asked questions
9592.SR · 4 questionsAlmujtama Alraida Medical Co. (9592.SR) reported revenue of $0.45B for 2025, up 5.6% year-over-year.
9592.SR revenue9592.SR salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-15